scholarly journals The The Effects of Zumba Exercise on LDL Levels and Oxidative Stress of Young Adult Women

2021 ◽  
Vol 8 (2) ◽  
pp. 149-153
Author(s):  
Alda Aulia Rahma Ananto Putri ◽  
Yuswo Supatmo ◽  
Erna Setiawati ◽  
Endang Ambarwati

ABSTRAK Latar Belakang: Gaya hidup sedenter menyebabkan penurunan aktivitas fisik yang merupakan faktor terjadinya penyakit tidak menular salah satunya dislipidemia. Zumba sebagai bentuk latihan aerobik yang banyak diminati oleh dewasa muda dapat menurunkan kadar LDL dan tingkat stres oksidatif yang diukur dengan biomarker malondialdehid (MDA). Tujuan: Mengetahui pengaruh latihan Zumba terhadap kadar LDL dan MDA pada wanita usia dewasa muda. Metode: Penelitian ini merupakan jenis penelitian eksperimental dengan rancangan two groups pre and post test design. Subjek penelitian sebanyak 36 orang wanita, dibagi menjadi kelompok perlakuan (n=18) dan kelompok kontrol (n=18). Kelompok perlakuan melakukan latihan Zumba selama 60 menit dengan frekuensi 2 kali seminggu selama 8 minggu secara virtual. Pengukuran kadar LDL dan MDA menggunakan sampel darah subjek penelitian. Analisis data dengan uji t-berpasangan, uji Wilcoxon dan uji Mann-Whitney. Hasil: Tidak terdapat penurunan kadar LDL namun terjadi penurunan kadar MDA yang signifikan pada kelompok perlakuan setelah latihan Zumba selama 8 minggu. Pada kelompok perlakuan kadar LDL meningkat dari 94,18±25,60 mg/dL menjadi 105,82±27,64 mg/dL (p<0,05) dan kadar MDA menurun dari 1,71±0,28 µmol/L menjadi 0,37±0,64 µmol/L (p<0,05). Tidak terdapat perbedaan kadar LDL yang bermakna, sebaliknya terdapat perbedaan kadar MDA yang bermakna antara kelompok perlakuan dan kontrol. Simpulan: Latihan Zumba dengan frekuensi 2 kali seminggu selama 8 minggu secara virtual tidak dapat menurunkan kadar LDL namun dapat menurunkan kadar MDA secara signifikan. Kata kunci: latihan Zumba, low density lipoprotein, malondialdehid

2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Zoe Irwin ◽  
Emeir M. McSorley ◽  
Mary M. Slevin ◽  
Lisa Rowan ◽  
Paul McMillen ◽  
...  

AbstractEvidence from observational studies indicates that seaweed consumption may reduce the risk of non-communicable diseases such as cardiovascular disease, type two diabetes, and obesity. Accumulating evidence from in vitro and animal studies suggest seaweed have antihyperlipidemic, anti-inflammatory and antioxidant properties which may in part be attributed to the high content of soluble dietary fibre in seaweeds. The viscosity of seaweed fibres is suggested to mediate antihyperlipdiemic effects via the alteration of lipid/bile acid absorption kinetics to decrease low-density lipoprotein cholesterol (LDL). Thus, there is a need to evaluate the efficacy of seaweed derived dietary fibre in the management of dyslipidemia. Therefore, the aim of this study was to determine the effect of a fibre rich extract from Palmaria palmata on the lipid profile as well as markers of inflammation and oxidative stress in healthy adults. A total of 60 healthy participants (30 male and 30 female) aged 20 to 58 years, were assigned to consume the Palmaria palmata fibre extract (5g/day), Synergy-1 and the placebo (maltodextrin) for a duration of 4 weeks with a minimum 4 week washout between each treatment in a double blind, randomised crossover study conducted over 5 months. Fasting concentrations of cholesterol, triglycerides and high-density lipoprotein cholesterol (HDL) were analysed and low-density lipoprotein cholesterol (LDL) and LDL: HDL ratio was calculated. C-reactive protein (CRP) and Ferric Reducing Ability of Plasma (FRAP) were analysed as markers of inflammation and oxidative stress, respectively. Supplementation for 4 weeks with Palmaria palmata resulted in favourable changes to lipid profiles with a reduced LDL:HDL ratio; however intention-to-treat univariate ANCOVA identified no significant difference between the treatment groups over time on any of the lipid profile markers. A non-significant increase in CRP and triglyceride concentration along with lower FRAP was also observed with Palmaria palmata supplementation. Evidence from this study suggests that Palmaria palmata may have effects on lipid metabolism and appears to mobilise triglycerides. More research is needed in individuals with dyslipidaemia to fully elucidate these effects.


2020 ◽  
pp. 1-3
Author(s):  
Deepthy C Sahadevan* ◽  
Archna Sing ◽  
Busi Karunanand ◽  
Himani Thakkar ◽  
Ajay Kumar Gautam

Objective: This study was designed to assess the apolipoprotein B (Apo-B), apolipoprotein A (Apo A) and Apo B/Apo A-I ratio in subjects with and withoutmetabolic syndrome andtoevaluate the correlationofApoB/ApoA-Iratiowithoxidative stressmarker andcardiovasculardisease risk. Methods:Atotal of 308 subjects including one hundred and fty- ve cases and one hundred and fty- three controls were recruited for this study. All the subjects were classied according to the NCEPATP III (National cholesterol education program – Adult treatment panel III) criteria for MetS. Anthropometric and clinical characteristics were recorded using clinical Proforma. Blood samples were collected for doing plasma glucose, Lipid prole analysis [Total Cholesterol (TC), Triglyceride (TG), high-density lipoprotein (HDL)], ApoA1, Apo B and oxidative stress marker - Malondialdehyde (MDA). Serum low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL) and Apo B/Apo A-I ratio were calculated. Comparison of data between the two groups was done by t test. Correlation coefcient of Apo B/ Apo A1 ratio with cadiometabolic risk factors were calculated. Result: We found that cardiometabolic risk factors like abdominal obesity, systolic and diastolic blood pressure, fasting plasma glucose, TG, atherogenic lipoproteins LDL, Apo B, Apo B/Apo A-I ratio and MDA were signicantly high in subjects with MetS whereas anti-atherogenic factor Apo A1 was signicantly low. We also observed that Apo B/AI ratio was positively related to cardiometabolic risk factors and with oxidative stress marker. Conclusion:Apo B/AI ratio was related to metabolic syndrome and was found to be a reliable indicator of cardiovascular risk in MetS.


Sign in / Sign up

Export Citation Format

Share Document